Scarica l'app Stockscreener
1.14
12.87%
0.13
Pre-mercato:
1.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Precedente Chiudi:
$1.01
Aprire:
$1.03
Volume 24 ore:
7.17M
Relative Volume:
1.34
Capitalizzazione di mercato:
$220.02M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-1.0654
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+8.57%
1M Prestazione:
+2.70%
6M Prestazione:
-39.36%
1 anno Prestazione:
-70.84%
Intervallo 1D:
$1.03
$1.16
Intervallo di 1 settimana:
$0.9631
$1.16
Portata 52W:
$0.88
$4.04
Humacyte Inc Stock (HUMA) Company Profile
Nome
Humacyte Inc
Settore
Industria
Telefono
919-313-9633
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.14 | 194.93M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.32 | 124.83B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
793.53 | 84.91B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
843.55 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.61 | 41.70B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
354.86 | 38.30B | 4.98B | 69.60M | 525.67M | 0.5198 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Iniziato | Barclays | Overweight |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-20 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-14 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Iniziato | Cowen | Outperform |
| 2021-09-24 | Iniziato | Oppenheimer | Outperform |
| 2021-09-22 | Iniziato | BTIG Research | Buy |
| 2021-09-16 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Humacyte Inc Borsa (HUMA) Ultime notizie
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Symvess Battlefield Trauma Potential - Yahoo! Finance Canada
Humacyte Shares Surge on US Defense Funding News - StocksToTrade
Humacyte, Inc. (NASDAQ:HUMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Humacyte promotes critical role of vascular health in February - Traders Union
Surprises Report: Whats the fair value of Humacyte Inc stock2025 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Chart Watch: Why Humacyte Inc. Equity Warrant stock remains on buy listsRate Hike & Reliable Breakout Forecasts - mfd.ru
Can Humacyte Inc. sustain earnings growthQuarterly Trade Review & High Conviction Investment Ideas - mfd.ru
Does Humacyte Inc. Equity Warrant stock benefit from AI growth2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru
Is Humacyte Inc. a speculative investmentJuly 2025 Intraday Action & Stepwise Trade Execution Plans - mfd.ru
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Battlefield Vascular Repair Potential - Sahm
HUMA stock just shot up 12% today – here’s everything to know about the DOD funding fueling the surge - MSN
Aug Levels: Should I invest in Humacyte Inc Equity Warrant before earnings - baoquankhu1.vn
Sell Signal: Can Humacyte Inc deliver consistent EPS growthJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Why Humacyte (HUMA) Is Up 5.1% After New DoD Funding Backs Symvess Trauma Use - simplywall.st
What’s the fair value of Humacyte Inc. stockEarnings Risk Summary & Verified Technical Signals - mfd.ru
Bond Watch: Can Humacyte Inc deliver consistent EPS growthWeekly Investment Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
HUMA Stock Soars Amid Strategic Business Moves and Financial Outlook - StocksToTrade
HUMA Stock Shows Volatility Amid Speculation and Economic Factors - timothysykes.com
Why Humacyte (HUMA) Is Up 19.6% After New DoD Funding For Biologic Vascular Repair - Yahoo Finance
Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA) - Seeking Alpha
Humacyte rises on Department of Defense funding for lab-made blood vessels - TradingView
Humacyte (NASDAQ:HUMA) Earns "Buy" Rating from D. Boral Capital - MarketBeat
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news - Investing.com
Humacyte Secures DOD Funding for Bioengineered Blood Vessels - Intellectia AI
HUMA Stock Is Soaring Today – Here’s Everything To Know About The DOD Funding Fueling The Surge - Stocktwits
Humacyte says new U.S. law backs bioengineered vessels (HUMA) - Seeking Alpha
Humacyte announces new U.S. Department of Defense funding for procurement of bioengineered blood vessels - marketscreener.com
Humacyte Says US DoD to Provide Funding for Procurement of Bioengineered Blood Vessels; Shares Rise - marketscreener.com
Humacyte Announces New U.S. Department Of Defense Funding For Procurement Of Bioengineered Blood Vessels - TradingView
Humacyte stock jumps after securing DoD funding for vascular repair tech - Investing.com
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge - Asianet Newsable
Pentagon backs lab-grown blood vessels for wounded troops - Stock Titan
RSI Check: Can Humacyte Inc sustain its profitabilityJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Breakouts Watch: Will Humacyte Inc benefit from rising consumer demandMarket Growth Review & High Win Rate Trade Tips - baoquankhu1.vn
Humacyte set to unveil advances in vascular surgery innovation - Traders Union
Macro Review: Will Humacyte Inc benefit from green energy policiesWeekly Loss Report & Weekly High Return Opportunities - baoquankhu1.vn
Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Does Humacyte Inc Equity Warrant have declining or rising EPSBuy Signal & Daily Momentum Trading Reports - baoquankhu1.vn
Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 648% Potential Upside - DirectorsTalk Interviews
Is Humacyte Inc. Equity Warrant in a long term uptrendTrade Risk Assessment & Technical Pattern Based Buy Signals - mfd.ru
Is Humacyte Inc. stock forming a triangle patternBull Run & Advanced Swing Trade Entry Plans - Mfd.ru
Aug Retail: Can Humacyte Inc sustain its profitability2025 Stock Rankings & Safe Entry Point Identification - baoquankhu1.vn
Pharma News: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR2025 Short Interest & Community Verified Swing Trade Signals - baoquankhu1.vn
Smart Money: What is the target price for Humacyte Inc Equity Warrant stockRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Rate Cut: What is the target price for Humacyte Inc Equity Warrant stockNew Guidance & Daily Growth Stock Tips - baoquankhu1.vn
Humacyte (HUMA) Valuation Check As Financing And Israel Filing Plans Lift Investor Interest - Sahm
Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn
Stop Loss: Will Humacyte Inc benefit from rising consumer demandRisk Management & Technical Confirmation Trade Alerts - baoquankhu1.vn
Humacyte Ends Sale Agreement with Jefferies LLC - MSN
Humacyte Inc Azioni (HUMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):